Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.

Description

The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.

Conditions

Peripheral Neuropathy Due to Chemotherapy

Study Overview

Study Details

Study overview

The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.

Fall Risk and Quality of Life: Influence of Dual Task Performance, Cognition, and Sensorimotor Variables in Individuals With Cancer Treatment Related Peripheral Neuropathy.

Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.

Condition
Peripheral Neuropathy Due to Chemotherapy
Intervention / Treatment

-

Contacts and Locations

Dallas

Texas Woman's University, Dallas, Texas, United States, 75235

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Individuals 18 years and older
  • * diagnosed with non- CNS cancer who underwent treatment and presents with peripheral neuropathy symptoms.
  • * age (+/- one year) and gender matched individuals
  • * no diagnosed peripheral neuropathy
  • * No diagnosed cognitive symptoms.
  • * Unable to follow two step commands.
  • * Unable to ambulate x 50 feet independently without use of an assistive device.
  • * Unable to use a phone to send text messages.
  • * Diagnosis of diabetic peripheral neuropathy
  • * Diagnosis of CNS cancer.
  • * Unable to speak/understand English

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Texas Woman's University,

Priya Karakkattil, PhD, PRINCIPAL_INVESTIGATOR, Texas Woman's University

Asha Vas, PhD, PRINCIPAL_INVESTIGATOR, Texas Woman's University

Study Record Dates

2025-06